Cleared Special

K171481 - MagVita TMS Therapy System (FDA 510(k) Clearance)

Jun 2017
Decision
28d
Days
Class 2
Risk

K171481 is an FDA 510(k) clearance for the MagVita TMS Therapy System. This device is classified as a Transcranial Magnetic Stimulator (Class II - Special Controls, product code OBP).

Submitted by Tonica Elektronik A/S (Farum, DK). The FDA issued a Cleared decision on June 16, 2017, 28 days after receiving the submission on May 19, 2017.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5805. A Transcranial Magnetic Stimulator Is A Device That Delivers Brief Duration, Rapidly Alternating, Or Pulsed, Magnetic Fields To Induce Electrical Currents That Are Directed At Spatially Discrete Regions Of The Cerebral Cortex For The Treatment Of Major Depressive Disorder..

Submission Details

510(k) Number K171481 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 19, 2017
Decision Date June 16, 2017
Days to Decision 28 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code OBP - Transcranial Magnetic Stimulator
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5805
Definition A Transcranial Magnetic Stimulator Is A Device That Delivers Brief Duration, Rapidly Alternating, Or Pulsed, Magnetic Fields To Induce Electrical Currents That Are Directed At Spatially Discrete Regions Of The Cerebral Cortex For The Treatment Of Major Depressive Disorder.